ESR1 and ductal breast carcinoma in situ: For example, RBBP7 (RbAp46) and BIRC5 (survivin) expression in carcinoma cells is significantly higher in estrogen receptor (ER)-positive pure DCIS than in invasive ductal carcinoma (IDC) [5].